GOI, GIANCARLO
 Distribuzione geografica
Continente #
EU - Europa 6.405
NA - Nord America 5.568
AS - Asia 4.829
SA - Sud America 377
AF - Africa 78
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 17.270
Nazione #
US - Stati Uniti d'America 5.367
GB - Regno Unito 2.607
CN - Cina 1.526
SG - Singapore 1.499
IT - Italia 1.083
SE - Svezia 561
DE - Germania 510
RU - Federazione Russa 486
HK - Hong Kong 429
TR - Turchia 288
BR - Brasile 267
VN - Vietnam 252
FR - Francia 251
UA - Ucraina 209
IN - India 204
KR - Corea 194
BD - Bangladesh 193
IE - Irlanda 161
NL - Olanda 146
CA - Canada 140
FI - Finlandia 140
EU - Europa 93
DK - Danimarca 89
JP - Giappone 48
CO - Colombia 43
ID - Indonesia 43
BE - Belgio 35
MX - Messico 31
AR - Argentina 27
PL - Polonia 27
ES - Italia 22
ZA - Sudafrica 21
IQ - Iraq 19
PK - Pakistan 18
GR - Grecia 17
UZ - Uzbekistan 15
SA - Arabia Saudita 14
EC - Ecuador 12
CI - Costa d'Avorio 11
PH - Filippine 11
VE - Venezuela 11
EG - Egitto 10
AE - Emirati Arabi Uniti 8
IR - Iran 8
AU - Australia 7
CH - Svizzera 7
CL - Cile 7
IL - Israele 7
MA - Marocco 7
MY - Malesia 7
BY - Bielorussia 6
JM - Giamaica 6
KE - Kenya 6
LT - Lituania 6
NP - Nepal 6
RO - Romania 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
BG - Bulgaria 5
AL - Albania 4
AT - Austria 4
AZ - Azerbaigian 4
BH - Bahrain 4
CZ - Repubblica Ceca 4
NG - Nigeria 4
RS - Serbia 4
SV - El Salvador 4
UY - Uruguay 4
AM - Armenia 3
CR - Costa Rica 3
GE - Georgia 3
IM - Isola di Man 3
PY - Paraguay 3
TN - Tunisia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TG - Togo 2
BB - Barbados 1
BJ - Benin 1
CD - Congo 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
Totale 17.342
Città #
Southend 2.419
Singapore 828
Ashburn 650
Chandler 465
Hong Kong 405
Milan 383
San Jose 379
Beijing 320
Seattle 294
Santa Clara 230
Princeton 226
Ann Arbor 214
Wilmington 206
Dublin 159
Council Bluffs 150
Dallas 139
Redmond 135
Los Angeles 126
Dearborn 116
Mountain View 113
Fairfield 102
Jacksonville 98
Bengaluru 93
Lauterbourg 91
Nanjing 90
Boardman 86
Des Moines 85
Phoenix 82
Sakarya 82
Woodbridge 78
Toronto 74
Munich 70
New York 69
Buffalo 68
Ho Chi Minh City 68
Moscow 65
The Dalles 57
Frankfurt am Main 54
Somerville 53
Guangzhou 52
Jinan 46
Shanghai 46
Hanoi 44
Houston 43
Tokyo 42
Bogotá 38
Hefei 38
Serra 37
Andover 36
Brussels 33
Hebei 33
Cambridge 32
Columbus 32
Helsinki 32
Istanbul 32
Shenyang 32
Turin 31
Berlin 29
Biella 29
Cangzhou 29
Dong Ket 28
Rome 28
Changsha 27
São Paulo 26
Nanchang 24
Jakarta 23
Tianjin 23
Hangzhou 22
Ottawa 22
Eitensheim 21
Roxbury 19
Shenzhen 18
Quanzhou 17
Redwood City 17
Seoul 17
Fuzhou 16
Kiez 16
Odernheim 15
Orem 15
San Diego 15
Zhengzhou 15
Athens 14
Jiaxing 13
Naples 13
Warsaw 13
Auburn Hills 12
Da Nang 12
Ningbo 12
Nürnberg 12
Abidjan 11
Bühl 11
Haikou 11
London 11
Turku 11
Atlanta 10
Bergamo 10
Brooklyn 10
Como 10
Falls Church 10
Sunnyvale 10
Totale 10.828
Nome #
Effects of Vitamin E-Stabilized Ultra High Molecular Weight Polyethylene on Oxidative Stress Response and Osteoimmunological Response in Human Osteoblast 366
Lag-time in Alzheimer's disease patients: A potential plasmatic oxidative stress marker associated with ApoE4 isoform 347
Levels of l-arginine and l-citrulline in patients with erectile dysfunction of different etiology 327
Plasmatic Soluble Receptor for Advanced Glycation End Products as a New Oxidative Stress Biomarker in Patients with Prosthetic-Joint-Associated Infections? 309
Erythrocyte membrane alterations during ageing affect beta-D-glucuronidase and neutral sialidase in elderly healthy subjects 292
Activity of human erythrocyte membrane-bound glycohydrolases is related to Plasmodium Falciparum products 283
Dexamethasone-Induced Skeletal Muscle Atrophy Increases O-GlcNAcylation in C2C12 Cells 278
Hexosaminidase activity of erythrocytes plasma membrane as a possible biomarker of oxidative stress and kidney conditions in old patients with chronic renal failure under renal replacement therapy 276
Acidic and neutral sialidase in the erythrocytes of patients with type 2 diabetics : an answer to comments by Richard et al 275
Le glicoidrolasi degli eritrociti nella comprensione dell’invecchiamento accelerato dei soggetti down 260
Levels of Human Erythrocyte Membrane-Bound and Cytosolic Glycohydrolases Are Associated with Oxidative Stress in Erectile Dysfunction Patients 256
OptiScanner 5000 : an intermittent glucose monitoring in septic patients 246
Effect of physiological concentration of phloridzin on normal and diabetic human erythrocytes under oxidative stress 239
Acidic and neutral sialidase in the erythrocyte membrane of type 2 diabetic patients 237
Advanced Oxidation Protein Products (AOPP) per monitorare lo stress ossidativo ed un possibile stato infiammatorio cronico in un gruppo eterogeneo per età di soggetti con trisomia 21 235
Levels of uric acid in erectile dysfunction of different aetiology 233
Plasmatic soluble receptor for advanced glycation end products (SRAGE) as a new oxidative stress biomarker in patients with prosthetic-joint-associated infections 228
Human erythrocyte membrane–bound glycohydrolases activity is a ected by Plasmodium falciparum products 226
Supplementation with isoflavones : metabolic effects in young healty women 217
O-GlcNAcylation as marker of antioxidant effects of vitamin E-stabilized ultra high molecular weight polyethylene in human osteoblast 216
Erythrocyte glycohydrolases in subjects with trisomy 21 : could Down’s sindrome be a model of accelerated ageing? 214
Early retinol-binding protein levels are associated with growth changes in infants born to diabetic mothers 214
O-ß-N-Acetyl-D-glucosaminidase in erythrocytes of Italian air force acrobatic pilots 213
Low levels of occupational exposure to arsenic and antimony : effects on lysosomal glycohydrolase levels in plasma of exposed workers and in lymphocyte cultures 205
Levels of human erythrocyte’s glycohydrolases are associated to oxidative stress in patients with prosthetic-joint-associated infection 200
Isoenzyme pattern and partial characterization of hexosaminidases in the membrane and cytosol of human erythrocytes 194
Effects of lead and manganese on the release of lysosomal enzymes in vitro and in vivo 193
Gli enzimi lisosomali 191
Utilizzo dei fibroblasti in coltura nella diagnostica biochimica delle malattie da accumulo lisosomale 190
Characterization of human O-GlcNAcase and b-hexosaminidase during erythroid cells differentiation 189
O-ß-N-Acetyl-D-glucosaminidase in erythrocytes of Italian air force acrobatic pilots 189
Oxidative stress in elderly chronic renal failure patients : effects of renal replacement therapies on cell membrane fluidity 186
Alteration of some glycohydrolases activities present on erythrocyte plasma membrane in type 2 diabetic patients 183
HUMAN ERYTHROCYTE'S MEMBRANE AND CYTOSOLIC GLYCOHYDROLASES AS NEW TOOL FOR THE EVALUATION OF OXIDATIVE STRESS IN PATIENTS WITH PROSTHETIC-JOINT-ASSOCIATED INFECTION 174
GLICOIDROLASI DI ORIGINE LISOSOMALE NEL PLASMA DI SOGGETTI DIABETICI ALL'ESORDIO 173
Proadrenomedullin levels in the early phase of septic shock 172
Whole Blood alpha-D-Galactosidase A activity for the identification of Fabry patients 170
O-β-N-acetylglucosaminidase on human erythrocytes as biomarker of oxidative stress in erectile disfunction patients 170
Lag-time as a plasmatic oxidative stress marker associated with apoe4 carrier status in Alzheimer's disease patients 170
Advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in an atheroma-free model : Down's syndrome 168
Alterations in the activity of several glycohydrolases in red blood cell membrane from type 2 diabetes mellitus patients 168
Lysosomal leukocyte b-D-Glucuronidase during enzyme replacemet therapy in Fabry disease 167
Effect of physiological concentration of caffeic acid on normal and diabetic human erythrocytes under oxidative stress 166
Cytosolic sialidase in developing rat forebrain 166
Lysosomal leukocyte beta-D-glucuronidase during enzyme replacement therapy in Fabry disease 165
O-GLcNACase as biomarker of antioxidant status in healty women under isoflavones supplementation 165
Gli enzimi lisosomiali 165
Effect of physiological concentration of tyrosol on normal and diabetic human erythrocytes under oxidative stress 164
Whole-blood alpha-D-galactosidase A activity for the identification of Fabry's patients 164
Evaluation of bone metabolism markers in patients with chronic benign and malignant pancreatic diseases 163
A new tool for the identification of fabry’s patients: assay of alpha-d-galactosidase a activity in whole-blood 162
Oxidated low-density lipoproteins (oxLDL) and peroxides in plasma of Down syndrome patients 160
Alterazione della fluidità della membrana eritrocitaria in pazienti sottoposti a dialisi peritoneale 159
Decrease of O-beta-N-acetylglucosaminidase expression in murine skeletal muscle cell atrophy 158
Behaviour of several enzymes of lysosomal origin in human plasma during pregnancy 155
alpha-L-fucosidase 155
COINVOLGIMENTO E POTENZIALE SIGNIFICATO DIAGNOSTICO DI ALCUNI ENZIMI LISOSOMALI NELLA BRONCODISPLASIA POLMONARE 155
Polymorphisms in the a-L-Iduronidase gene is associated with progression rate in IGA nephropathy 153
Oxidative stress in chronic renal failure in old patients : effects of different renal replacement therapies on cell membrane fluidity 153
Membrane anchoring and surface distribution of glycohydrolases of human erythrocyte membrane 151
BIOLOGIA MOLECOLARE DEI RECETTORI 151
Metodi per la diagnostica enzimatica delle sfingolipidosi 150
Fabry disease’s screening : activity of α-D-galactosidase A in whole blood 149
Cytosolic sialidase from the nerve endings of developing rat forebrain 149
EFFETTO DELL'ARSENICO SUL RILASCIO DI ENZIMI LISOSOMALI DA LINFOCITI UMANI IN CULTURA 148
THE ESTERS OF P-HYDROXY-BENZOATE (PARABENS) INHIBIT THE RELEASE OF LYSOSOMAL-ENZYMES BY MITOGEN-STIMULATED PERIPHERAL HUMAN-LYMPHOCYTES IN CULTURE 147
Clinical enzymology of inherited lysosomal diseases 147
Decrease activity and expression of O-beta-N-acetylglucosaminidase in murine skeletal muscle cell atrophy 147
Isoenzyme pattern and partial characterizazion of hexosaminidases in human erythrocytes 146
Enzymes of lysosomal origin in human plasma and serum: assay conditions and parameters influencing the assay 146
ENZYMES OF LYSOSOMAL ORIGIN IN THE CEREBROSPINAL-FLUID AND PLASMA OF PATIENTS WITH MULTIPLE-SCLEROSIS 146
AUTOMATED FLUOROMETRIC ASSAY PROCEDURE FOR GLUCOHYDROLASES USING A ROUTINE CENTRIFUGAL ANALYZER ASSAY OF ENZYMES OF LYSOSOMAL ORIGIN IN PLASMA .2 145
Plasma glycohydrolases levels in patients with type 1 diabetes at onset, and in subjects undergoing intravenous glucose tolerance test 144
Plasma lysosomal glycohydrolases in a general population 144
EFFETTO DEL PIOMBO E DEL MANGANESE SUL RILASCIO DI ENZIMI LISOSOMALI IN SOGGETTI ESPOSTI E IN UNA POPOLAZIONE GENERALE 144
Isoflavone supplementation reduces DNA oxidative damage and increases O-β-N-acetyl-D-glucosaminidase activity in healthy women 143
O-beta-N-Acetylglucosaminidase on human Erythrocytes as biomarker of oxidative stress in erectile disfunction patients. 143
Lysosomal enzymes in preterm infants with bronchopulmonary dysplasia: a potential diagnostic marker 142
Plasmodium falciparum products affect human erythrocyte membrane-bound glycohydrolases activity 141
Lysosomal enzymes in lymphocytes and plasma of women with non-malignant, pre-malignant and malignant pathology of the breast 139
Enzymes of lysosomal origin in the serum of infants of diabetic mothers : behavior in the 1st days after birth 136
Behaviour of several enzymes of lysosomal origin in human plasma during whole blood storage 136
BEHAVIOR OF SOME LYSOSOMAL-ENZYMES IN THE PLASMA OF INSULIN-DEPENDENT DIABETIC-PATIENTS DURING ARTIFICIAL PANCREAS TREATMENT 135
ENZYMES OF LYSOSOMAL ORIGIN IN PLASMA OF TWIN NEONATES 133
SERUM ENZYMES OF LYSOSOMAL ORIGIN AS INDICATORS OF THE METABOLIC CONTROL IN DIABETES - COMPARISON WITH GLYCATED HEMOGLOBIN AND ALBUMIN 132
THE LYSOSOMAL BETA-D-N-ACETYLGLUCOSAMINIDASE ISOZYMES IN HUMAN-PLASMA DURING PREGNANCY - SEPARATION AND QUANTIFICATION BY A SIMPLE AUTOMATED PROCEDURE 132
GLICOIDROLASI DELLA MEMBRANA ERITROCITARIA IN PAZIENTI AFFETTI DA DIABETE MELLITO TIPO II 131
PREPARATION OF A STABLE LIQUID MATERIAL FOR CALIBRATION AND QUALITY-CONTROL FOR LYSOSOMAL-ENZYMES IN PLASMA .1. ASSAY OF ENZYMES OF LYSOSOMAL ORIGIN IN PLASMA 125
SERUM ENZYMES OF LYSOSOMAL ORIGIN AS INDICATORS OF THE METABOLIC CONTROL IN NON-INSULIN-DEPENDENT DIABETICS 124
Levels of some lysosomal activities in newborns 123
Chronobiological rhythms of seven lysosomal enzymes and other analytes in sixteen young women 123
Glycated albumin in the plasma of insulin dependent diabetics. Determination by a new and simple affinity chromatographic-colorimetric test kit 119
Sandhoff's disease (GM2 gangliosidosis type O) 119
CIRCADIAN AND CIRCANNUAL RHYTHMS OF SEVERAL ENZYMES OF LYSOSOMAL ORIGIN IN HUMAN-PLASMA 118
Gli enzimi di origine lisosomale nei liquidi biologici: determinazione e potenziale diagnostico 118
Lysosomal glycohydrolases in normal T and non-T peripheral lymphocytes 111
CHRONOBIOLOGICAL STUDY OF SEVERAL ENZYMES OF LYSOSOMAL ORIGIN IN HUMAN-PLASMA 110
LYSOSOMAL-ENZYMES IN NORMAL AND PATHOLOGICAL PREGNANCIES 108
Influence of age and sex on five human plasma lysosomal enzymes assayed by automated procedures 107
Study of some lysosomal glycohydrolases in tumors of the nervous system 107
Totale 17.676
Categoria #
all - tutte 47.611
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.611


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.122 161 62 30 36 129 37 78 49 108 110 87 235
2022/20231.531 191 148 174 137 196 298 32 106 188 13 38 10
2023/2024836 12 106 28 37 258 69 31 46 15 40 77 117
2024/20252.090 76 194 31 235 250 64 36 184 143 129 210 538
2025/20264.617 461 291 432 300 554 348 572 198 466 372 323 300
2026/20273 3 0 0 0 0 0 0 0 0 0 0 0
Totale 18.142